Publicly-traded companies with excess cash will sometimes buy back its own stock instead of paying a dividend or making an acquisition. By doing so, a business can boost its future earnings per share without having to make any operational improvements or significantly increase revenue. That being said, the names on our list today have bought back the biggest amount of its own stock.
Apple Inc. (NASDAQ: AAPL) – $116.17
Computer Hardware
Apple Inc. designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players and sells a variety of related software, services, peripherals, networking solutions and third-party digital content and applications. The Company’s products and services include iPhone, iPad, Mac, iPod, Apple TV, a portfolio of consumer and professional software applications, the iOS and OS X operating systems, iCloud and a variety of accessory, service and support offerings.
- Market Cap: $644,619,770,220
- Total Revenue (LTM): $233,715,000,000
- Shares Outstanding (LFQ): 5,578,753,000
- Issuance/(Retirement) of Stock: -$13,201,000,000
Related: 5 U.S. Stocks Fit For Giving This Holiday Season >>>
Microsoft Corp. (NASDAQ: MSFT) – $55.27
Software
Microsoft Corporation is engaged in developing, licensing and supporting a range of software products and services. The Company also designs and sells hardware, and delivers online advertising to the customers. Microsoft operates in five segments: Devices and Consumer (D&C) Licensing, D&C Hardware, D&C Other, Commercial Licensing, and Commercial Other. The Company’s products include operating systems for computing devices, servers, phones, and other intelligent devices; server applications for distributed computing environments; productivity applications; business solution applications; desktop and server management tools; software development tools; video games; and online advertising.
- Market Cap: $439,175,465,097
- Total Revenue (LTM): $90,758,000,000
- Shares Outstanding (LFQ): 7,986,000,000
- Issuance/(Retirement) of Stock: -$4,538,000,000
American International Group Inc. (NYSE: AIG) – $60.98
Property & Casualty Insurance
American International Group, Inc. (AIG) is an insurance company that provides a range of property casualty insurance, life insurance, retirement products, mortgage insurance and other financial services. Its various offerings include products and services that help businesses and individuals protect their assets, manage risks and provide for retirement security. AIG operates through two segments: Commercial Insurance and Consumer Insurance. Commercial Insurance is a provider of insurance products and services for commercial and institutional customers.
- Market Cap: $76,917,437,996
- Total Revenue (LTM): $60,602,000,000
- Shares Outstanding (LFQ): 1,246,794,620
- Issuance/(Retirement) of Stock: -$3,730,000,000
Looking for more hidden gems? Get your free Ubika Mining 20 Monthly report.
The Ubika Mining 20 (UM20) index slipped 3.4% during the past month yet handily beat the 13.1% slump by the TSX Mining Index, UM20’s closest benchmark. The TSX Venture index, meanwhile, eased 1.3%. Lucara Diamond Corp. (TSX: LUC) was the top-performing component company this month, powering 27% higher after announcing the recovery of the second largest gem-quality diamond ever mined. Get your copy of the Ubika Mining 20 report here >>
Gilead Sciences Inc. (NASDAQ: GILD) – $102.62
Biotechnology & Medical Research
Gilead Sciences, Inc. (Gilead), is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines. The Company’s primary areas of focus include human immunodeficiency virus (HIV), liver diseases such as chronic hepatitis C virus (HCV) infection and chronic hepatitis B virus (HBV) infection, oncology and inflammation, and serious cardiovascular and respiratory conditions.
- Market Cap: $146,928,319,963
- Total Revenue (LTM): $31,447,269,000
- Shares Outstanding (LFQ): 1,449,000,000
- Issuance/(Retirement) of Stock: -$2,971,000,000
Biogen Inc. (NASDAQ: BIIB) – $289.88
Pharmaceuticals
Biogen Inc., formerly Biogen Idec Inc., is a global biopharmaceutical company that is focused on discovering, developing, manufacturing and delivering therapies for neurological, autoimmune and hematologic disorders. The Company develops, manufactures and markets products designed for the treatment of multiple sclerosis (MS) and hemophilia A and B.
- Market Cap: $63,440,453,852
- Total Revenue (LTM): $10,565,139,000
- Shares Outstanding (LFQ): 222,903,110
- Issuance/(Retirement) of Stock: -$2,945,215,000
